Roberto Ferri

Sorin SpA engages in the research, development, and manufacture of technology products for the treatment of cardiovascular diseases. It operates through the Cardiac Surgery and Cardiac Rhythm business segments. The Cardiac Surgery segment involves in the production and marketing of single-use biomedical devices, systems used to ensure out-of-body circulation in cardiac surgical procedures, and implantable prosthetics to replace or repair heart valves. The Cardiac Rhythm segment deals with the production and marketing of implantable devices and monitoring equipment and accessories to protect against heartbeat disorders. The company was founded in 1956 and is headquartered in Milan, Italy.

GlaxoSmithKline SpA manufactures and distributes pharmaceutical products. The firm offers prescription pharmaceuticals and vaccines, over-the-counter medicines, oral care and nutritional healthcare products. The company was founded on March 30, 1932 and is headquartered in Verona, Italy.